These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
149 related items for PubMed ID: 11840388
21. Caring for the renal failure patient: optimizing iron therapy. Folkert VW, Javier AM, O'Mara NB. Nephrol Nurs J; 2002 Dec; 29(6):586-93; quiz 594-5. PubMed ID: 12596608 [Abstract] [Full Text] [Related]
22. [Therapeutic guidelines for renal anemia in Japan]. Naito M, Akiba T. Nihon Rinsho; 2004 Jun; 62 Suppl 6():562-5. PubMed ID: 15250369 [No Abstract] [Full Text] [Related]
28. III. Clinical practice recommendations for anemia in chronic kidney disease in children. KDOQI, National Kidney Foundation. Am J Kidney Dis; 2006 May; 47(5 Suppl 3):S86-108. PubMed ID: 16678669 [No Abstract] [Full Text] [Related]
29. Adjusting i.v. iron and EPO doses in patients on hemodialysis prior to continuing surgery: can we protect our patients education from iron-deficiency anemia? Deaver K, Bennington L. Nephrol Nurs J; 2006 May; 33(4):430-7; quiz 438. PubMed ID: 17002001 [Abstract] [Full Text] [Related]
30. Intravenous iron supplementation for the treatment of anaemia in pre-dialyzed chronic renal failure patients. Mircescu G, Gârneata L, Capusa C, Ursea N. Nephrol Dial Transplant; 2006 Jan; 21(1):120-4. PubMed ID: 16144853 [Abstract] [Full Text] [Related]
31. [Is the management of anemia in hemodialysis patients improving in France? Results of the DiaNE study]. Kessler M, Landais P, Canivet E, Yver L, Bataille P, Brillet G, Commenges B, Koné S. Nephrol Ther; 2009 Apr; 5(2):114-21. PubMed ID: 19042175 [Abstract] [Full Text] [Related]
32. [Iron supplementation during erythropoietin therapy in patients on hemodialysis]. Svára F, Sulková S, Kvasnićka J, Polakovic V. Vnitr Lek; 1996 Dec; 42(12):849-52. PubMed ID: 9072885 [Abstract] [Full Text] [Related]
35. Safety of intravenous iron in clinical practice: implications for anemia management protocols. Aronoff GR. J Am Soc Nephrol; 2004 Dec; 15 Suppl 2():S99-106. PubMed ID: 15585604 [No Abstract] [Full Text] [Related]
36. [Methoxy polyethylene glycol-epoetin beta (Mircera) in the treatment of a patient with chronic kidney disease presenting late-onset hypersensitivity to other epoetins]. Dávila Fajardo CL, Peña Ortega M, Cabeza Barrera J, Prados Garrido MD. Nefrologia; 2010 Dec; 30(3):372-3. PubMed ID: 20514110 [No Abstract] [Full Text] [Related]
37. Intravenous iron in chronic kidney disease: haemoglobin change shortly after treatment of patients neither on dialysis nor on erythropoietin. Tagboto S, Cropper L, Mostafa S, Turner J, Bailey G, Pugh-Clarke K. J Ren Care; 2008 Sep; 34(3):112-5. PubMed ID: 18786076 [Abstract] [Full Text] [Related]
38. [Intravenous iron for the treatment of anemia in a day hospital: between inflammation and bleeding]. Méndez Bailón M, Muñoz Rivas N. Gastroenterol Hepatol; 2010 Dec; 33(10):755-6. PubMed ID: 21051114 [No Abstract] [Full Text] [Related]
39. Effects of intravenous iron combined with low-dose recombinant human erythropoietin on transfusion requirements in iron-deficient patients undergoing bilateral total knee replacement arthroplasty. Na HS, Shin SY, Hwang JY, Jeon YT, Kim CS, Do SH. Transfusion; 2011 Jan; 51(1):118-24. PubMed ID: 20624257 [Abstract] [Full Text] [Related]